-
A PHASE 1B, FIRST IN HUMAN, DOSE ESCALATION AND EXPANSION, MULTICENTER STUDY OF XMT- 1660 IN PARTICIPANTS WITH SOLID TUMORS
Monika Chaudhry | June 4, 2022
COVID-19: We are currently offering vaccinations to current qualifying patients. CURRENT PATIENTS VACCINATION INFO.